Member Exclusive

New paper from FDA commissioner lays roadmap for regulating "modern products" with "traditional tools"

The Special Report, published in the New England Journal of Medicine, describes the FDA’s goals in stem cell oversight.

Go to the profile of Freya Leask
Mar 13, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.